[
Cannon M.J., D.S. Schmid and T.B. Hyde. 2010. Reviev of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 20: 202–213.10.1002/rmv.655
]Search in Google Scholar
[
Czarkowski M.P., B. Kondej, E. Staszewska-Jakubik and E. Cielebąk. 2016. Vaccinations in Poland in 2015 (in Polish). http://wwwold.pzh.gov.pl/oldpage/epimeld/2015/Sz_2015.pdf. 2017.01.16.
]Search in Google Scholar
[
European Centre for Disease Prevention and Control. 2016. Measles and rubella monitoring, July 2016 – Disease surveillance data: 1 July 2015 – 30 June 2016. Stockholm: ECDC. https://ecdc.europa.eu/en/publications/Publications/measles-rubella-monitoring-july-2016.pdf. 2017.01.16.
]Search in Google Scholar
[
Gaj Z., M. Rycel, J. Wilczyński and D. Nowakowska. 2012. Seroprevalence of cytomegalovirus infection in the population of Polish pregnant women. Ginekol. Pol. 83: 337–341.
]Search in Google Scholar
[
Hamilton S.T., W. van Zuylen, A. Shand, G.M. Scott, Z. Naing, B. Hall, M.E. Craig and W.D. Rawlinson. 2014. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review. Rev. Med. Virol. 24: 420–433.10.1002/rmv.1814
]Search in Google Scholar
[
Kadambari S., E.J. Williams, S. Luck, P.D. Griffihs and M. Sharland. 2011. Evidence based management guidelines for the detection and treatment of congenital CMV. Early Hum. Dev. 87: 723–728.10.1016/j.earlhumdev.2011.08.021
]Search in Google Scholar
[
Lambert N., P. Strebel, W. Orenstein, J. Icenogle and G.A. Poland. 2015. Rubella. Lancet 385: 2297–2307.10.1016/S0140-6736(14)60539-0
]Search in Google Scholar
[
Ludwig A. and H. Hengel. 2009. Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro Surveill. 14(9): 26–32.10.2807/ese.14.09.19140-en
]Search in Google Scholar
[
Murray P.R., K.S. Rosenthal and M.A. Pfaller. 2011. Microbiology (in Polish). Elsevier Urban & Partner, Wrocław.
]Search in Google Scholar
[
Siennicka J., M. Dunal-Szczepaniak, A. Trzcińska, P. Godzik and M. Rosińska. 2016. High seroprevalence of CMV among women of childbearing age implicates high burden of congenital cytomegalovirus infection in Poland. Pol. J. Microbiol. 65: 425–432.10.5604/17331331.122766828735326
]Search in Google Scholar
[
Smits G., L. Mollema, S. Hahné, H. de Melker, I. Tcherniaevaa, F. van der Klis and G. Berbe. 2014 Seroprevalence of rubella antibodies in the Netherlands after 32 years of high vaccination coverage. Vaccine 32: 1890–1895.10.1016/j.vaccine.2014.01.06624513012
]Search in Google Scholar
[
Wujcicka W., Z. Gaj, J. Wilczyński, W. Sobala, E. Śpiewak and D. Nowakowska. 2014. Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011. Eur. J. Clin. Microbiol. Infect. Dis. 33: 1951–1958.10.1007/s10096-014-2170-3455544124902519
]Search in Google Scholar
[
Wysokińska T., W. Janaszek, B. Bucholc, P. Gorska, G. Gniadek, J. Slusarczyk and M. Rawicz. 2004 The prevalence of anti-rubella antibodies in women of childbearing age in Poland. Vaccine 22: 1899–1902.10.1016/j.vaccine.2003.11.00415121301
]Search in Google Scholar
[
Zimmerman L., J. Rogalska, K.A. Wannemuehler, M. Haponiuk, A. Kosek, E. Pauch, E. Plonska, D. Veltze, M.P. Czarkowski, N. Buddh and others. 2011. Toward Rubella elimination in Poland: Need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts. JID 204(Suppl 1): 389–395.
]Search in Google Scholar
